Table 1. Average number of copy number gains, losses and percent genome altered (PGA) across TCGA cancer types and the three exemplar tumors selected for our study.
TCGA | Exemplar tumors | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Average of all tumors | Tumor 1 | Tumor 2 | Tumor 3 | ||||||||
Cancer | Gains | Losses | Gains | Losses | PGA | Gains | Losses | PGA | Gains | Losses | PGA |
BLCA | 23 | 30 | 23 | 30 | 70% | 22 | 25 | 72% | 22 | 25 | 71% |
BRCA | 26 | 36 | 24 | 34 | 59% | 27 | 33 | 67% | 21 | 30 | 66% |
CRC | 24 | 42 | 27 | 48 | 27% | 23 | 29 | 70% | 22 | 30 | 69% |
GBM | 26 | 36 | 23 | 34 | 51% | 19 | 33 | 73% | 30 | 43 | 57% |
HNSC | 24 | 40 | 28 | 40 | 61% | 24 | 30 | 55% | 24 | 28 | 62% |
KIRC | 6 | 16 | 6 | 16 | 75% | 7 | 15 | 57% | 8 | 14 | 66% |
LUAD | 26 | 34 | 26 | 25 | 55% | 26 | 30 | 63% | 22 | 32 | 67% |
LUSC | 25 | 43 | 34 | 47 | 26% | 31 | 34 | 68% | 24 | 31 | 73% |
UCEC | 39 | 47 | 39 | 43 | 62% | 38 | 38 | 59% | 37 | 37 | 66% |
OV | 29 | 37 | 26 | 35 | 68% | 28 | 34 | 74% | 28 | 31 | 65% |